1 Min Read
Sept 28 (Reuters) - Zhejiang Huahai Pharmaceutical Co Ltd
* Says it received approval for its production base of API from U.S Food and Drug Administration
Source text in Chinese:goo.gl/S41WCf
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.